Aerogen

Aerogen is a world-leading medical technology company specializing in acute care aerosol drug delivery, with a strong focus on advanced vibrating mesh nebuliser solutions. Headquartered in Galway, Ireland, the company has built more than 25 years of expertise in respiratory care and is widely recognized for setting clinical standards in hospital-based aerosol therapy.

Aerogen’s proprietary vibrating mesh technology has been used in the treatment of more than 30 million respiratory patients across 80 countries. The company holds over 300 international patents and its technologies are supported by more than 300 clinical papers and scientific publications, reflecting a strong foundation of clinical evidence and research-driven innovation.

At the core of its portfolio is the Aerogen Solo vibrating mesh nebuliser, which has become the gold standard for aerosol drug delivery across multiple hospital settings, from emergency departments to intensive care units. Designed to deliver consistent and efficient aerosol therapy, Aerogen’s solutions are integrated into acute care workflows to support critically ill patients.

Through continued investment in research, technology development, and global clinical partnerships, Aerogen remains focused on advancing respiratory care and improving patient outcomes worldwide.